– GEN’s Editor-in-Chief Interviews Ian Wilmut, Ph.D., Director, Scottish Centre for Regenerative Medicine, University of Edinburgh, and Editor-in-Chief of Cloning & Stem Cells.

Previous articleCancer Drug Deal with Sanofi-Aventis Worth over $744M for Oxford BioMedica
Next articleLonza and Bio*One Capital Break Ground for Second Manufacturing Facility in Singapore